Vella L, Sternjakob A, Lohse S, Fingerle A, Sperling T, Wickenhauser C
Front Cell Infect Microbiol. 2024; 14:1336492.
PMID: 38510961
PMC: 10953690.
DOI: 10.3389/fcimb.2024.1336492.
Yoshimura T, Li C, Wang Y, Matsukawa A
Cell Mol Immunol. 2023; 20(7):714-738.
PMID: 37208442
PMC: 10310763.
DOI: 10.1038/s41423-023-01013-0.
Zanatta J, Acuna S, de Souza Angelo Y, de Almeida Bento C, Peron J, Stolf B
PLoS One. 2023; 18(3):e0283696.
PMID: 37000792
PMC: 10065296.
DOI: 10.1371/journal.pone.0283696.
Abd-Rabou A, Ahmed H, Mohamed S, Kotob S, Kishta M
Asian Pac J Cancer Prev. 2022; 23(12):4261-4274.
PMID: 36580009
PMC: 9971455.
DOI: 10.31557/APJCP.2022.23.12.4261.
Messeha S, Zarmouh N, Mendonca P, Cotton C, Soliman K
Mol Med Rep. 2020; 22(2):1213-1226.
PMID: 32627003
PMC: 7339712.
DOI: 10.3892/mmr.2020.11240.
More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis.
Gschwandtner M, Derler R, Midwood K
Front Immunol. 2020; 10:2759.
PMID: 31921102
PMC: 6923224.
DOI: 10.3389/fimmu.2019.02759.
Bevacizumab and CCR2 Inhibitor Nanoparticles Induce Cytotoxicity-Mediated Apoptosis in Doxorubicin-Treated Hepatic and Non-Small Lung Cancer Cells.
Abd-Rabou A, Ahmed H
Asian Pac J Cancer Prev. 2019; 20(7):2225-2238.
PMID: 31350989
PMC: 6745235.
DOI: 10.31557/APJCP.2019.20.7.2225.
The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells.
Messeha S, Zarmouh N, Mendonca P, Alwagdani H, Kolta M, Soliman K
PLoS One. 2018; 13(7):e0201116.
PMID: 30059519
PMC: 6066199.
DOI: 10.1371/journal.pone.0201116.
Protein Mimetic and Anticancer Properties of Monocyte-Targeting Peptide Amphiphile Micelles.
Poon C, Chowdhuri S, Kuo C, Fang Y, Alenghat F, Hyatt D
ACS Biomater Sci Eng. 2018; 3(12):3273-3282.
PMID: 29302619
PMC: 5749269.
DOI: 10.1021/acsbiomaterials.7b00600.
Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells.
An J, Xue Y, Long M, Zhang G, Zhang J, Su H
Oncotarget. 2017; 8(24):39230-39240.
PMID: 28424406
PMC: 5503609.
DOI: 10.18632/oncotarget.16837.
Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
Huang J, Basu S, Zhao X, Chien S, Fang M, Oehler V
Blood Cancer J. 2015; 5:e302.
PMID: 25860293
PMC: 4450324.
DOI: 10.1038/bcj.2015.17.
CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis.
Petrovic-Djergovic D, Popovic M, Chittiprol S, Cortado H, Ransom R, Partida-Sanchez S
Clin Exp Immunol. 2015; 180(2):305-15.
PMID: 25561167
PMC: 4408165.
DOI: 10.1111/cei.12579.
Xanthones from Securidaca inappendiculata exert significant therapeutic efficacy on adjuvant-induced arthritis in mice.
Zuo J, Xia Y, Li X, Chen J
Inflammation. 2014; 37(3):908-16.
PMID: 24419745
DOI: 10.1007/s10753-014-9810-8.
Ccr2-64i and Ccr5 Δ32 Polymorphisms in Patients with Late-Onset Alzheimer's disease; A Study from Iran (Ccr2-64i And Ccr5 Δ32 Polymorphisms in Alzheimer's disease).
Khorshid H, Manoochehri M, Nasehi L, Ohadi M, Rahgozar M, Kamali K
Iran J Basic Med Sci. 2013; 15(4):937-44.
PMID: 23493039
PMC: 3586912.
Characterization of three newly established rat sarcoma cell clones.
Holubova M, Leba M, Sedmikova M, Vannucci L, Horak V
In Vitro Cell Dev Biol Anim. 2012; 48(10):610-8.
PMID: 23150138
DOI: 10.1007/s11626-012-9563-3.
Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance.
Zhang X, Qin X, Qin C, Yin Y, Chen Y, Zhu H
Cancer Immunol Immunother. 2012; 62(3):563-70.
PMID: 23090289
PMC: 11028706.
DOI: 10.1007/s00262-012-1361-y.
3D-QSAR studies on CCR2B receptor antagonists: Insight into the structural requirements of (R)-3-aminopyrrolidine series of molecules based on CoMFA/CoMSIA models.
Gade S, Mahmood S
J Pharm Bioallied Sci. 2012; 4(2):123-33.
PMID: 22557923
PMC: 3341716.
DOI: 10.4103/0975-7406.94813.
Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.
Allavena P, Mantovani A
Clin Exp Immunol. 2012; 167(2):195-205.
PMID: 22235995
PMC: 3278685.
DOI: 10.1111/j.1365-2249.2011.04515.x.
Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.
Zhang J, Patel L, Pienta K
Prog Mol Biol Transl Sci. 2010; 95:31-53.
PMID: 21075328
PMC: 3197817.
DOI: 10.1016/B978-0-12-385071-3.00003-4.
Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease.
Hickman S, El Khoury J
CNS Neurol Disord Drug Targets. 2010; 9(2):168-73.
PMID: 20205643
PMC: 3684802.
DOI: 10.2174/187152710791011982.